Nuvilex - NVLX

Nuvilex (NVLX)
Coverage: March 1, 2013 - March 1, 2014
Featured: March 1, 2013

Latest Newsletter Editions

spacer
Mon, Mar 3, 2014 @ 05:03 am
Nuvilex (NVLX): Shorts Wreak of Desperation: New Highs Imminent Imagine my surprise when another hatchet article magically appeared...
Thu, Feb 27, 2014 @ 10:02 am
Nuvilex (NVLX): It Just Doesn't Get Any Better: Again This is my third edition in a row on Nuvilex (NVLX)- It's the certainly...
Mon, Feb 24, 2014 @ 09:02 am
The Nuvilex (NVLX) Nightmare- If You're A Short Seller I wonder if those hatchet men for the short sellers ever get tired of being...
Thu, Feb 20, 2014 @ 06:02 am
Nuvilex (NVLX): It Just Doesn't Get Any Better This is about as good as it gets in Penny Land. How about this month's call on...
Sun, Feb 9, 2014 @ 03:02 pm
Buckle In For An Exciting Ride I hope you've enjoyed the first month of 2014- It's been exciting.

Click Here For More Newsletters on NVLX

spacer

Latest Blog Entries

spacer

Quote Data

spacer
Last Trade: 0.349 Bid: 0.0000
Last Size: 835 Ask: 0.0000
Trade Time: 3:59pm Bid x Ask Size: N/A
Change: up arrow +0.0740 (+26.91%) Day's Range: 0.28 - 0.37
Prev Close: 0.2750 52wk Range: 0.07 - 0.62
Open: 0.2790 P/E (ttm): N/A
Volume: 12,427,481 EPS (ttm): -0.021
spacer [Chart]

Business Summary

spacer

Disclosure

spacer
MarketBtye LLC was formerly paid a fee of $10,000 and 1 million newly issued restricted shares of Nuvilex by the company for six months of coverage. The 6 months has expired. On November 1, 2013, MarketByte LLC entered into a consulting agreement with Nuvilex to cover the company for an additional 6 months and received 300,00 newly issued restricted shares.

Recent News Headlines

spacer
Nuvilex, Inc. Could Obtain FDA Accelerated Approval After Phase 2b Clinical Trial
Thu, 17 Apr 2014 12:45:00 GMT
[Marketwired] - Nuvilex, Inc. has once again delivered a major announcement as it advances its pancreatic cancer treatment toward late phase clinical trials. Nuvilex continues to put forth what is turning into a well ...
Nuvilex Contracts With Clinical Network Services Pty Ltd for Late-Phase Clinical Trials in Pancreatic Cancer
Tue, 15 Apr 2014 13:00:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that it has ...
By Popular Demand: Growth Capital Expo Day Two to Feature Expert Panel and Presentations by Top Marijuana-Related Companies
Mon, 14 Apr 2014 12:00:00 GMT
[Marketwired] - An expanded discussion of the prospects and trends in investment in legal marijuana-related businesses, plus presentations by publicly traded and pre-IPO cannabis-related companies, will be featured on ...
Nuvilex Engages ViruSure to Establish Cell Banks for Phase 2b Clinical Trials in Pancreatic Cancer
Thu, 10 Apr 2014 13:00:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, reported today that it has ...
Medical Marijuana Sciences' Dr. Mark L. Rabe Speaks at ASA Medical Cannabis Unity Conference in Washington DC
Tue, 08 Apr 2014 13:00:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Medical Marijuana Sciences, Inc., a subsidiary of Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the ...
Nuvilex Investors Should Read Between the Lines as Company Attracts World Renowned Oncologist
Thu, 03 Apr 2014 13:00:00 GMT
[Marketwired] - That loud noise you hear coming from Nuvilex, Inc. this week is the collective excitement of many investors after the company stated it would be working with Translational Drug Development or TD2 and Dr. ...
Nuvilex Selects Translational Drug Development (TD2) to Advance Treatment for Pancreatic Cancer
Tue, 01 Apr 2014 13:00:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that it has ...
Nuvilex to Present at National Medical Cannabis Unity Conference in Washington DC
Tue, 25 Mar 2014 13:00:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that holistic ...
NUVILEX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Tue, 25 Mar 2014 10:01:44 GMT
NUVILEX, INC. Financials
Fri, 21 Mar 2014 17:04:18 GMT
Nuvilex Contracts With Austrianova for cGMP-Compliant Cell-in-a-Box(R) Encapsulation of Cells for Clinical Trials
Thu, 20 Mar 2014 13:00:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that it has contracted ...
NUVILEX, INC. Files SEC form 8-K, Other Events
Thu, 20 Mar 2014 12:29:21 GMT
Nuvilex - Another Cannabis Story Stock
Tue, 18 Mar 2014 18:05:37 GMT
Professor Dr. Walter H. Gunzburg, Executive Chairman and Chief Technical Officer of Nuvilex Affiliate SG Austria, Presents at 2014 BioPharma Asia Convention in Singapore
Mon, 17 Mar 2014 12:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that Dr. Professor Walter ...
NUVILEX, INC. Files SEC form 10-Q, Quarterly Report
Mon, 17 Mar 2014 10:07:27 GMT
Cannabis Market News & Volume Leaders Briefing - Company Signs LOI For Washington State Cannabis Retail Outlets
Thu, 13 Mar 2014 12:59:00 GMT
[PR Newswire] - Medical marijuana industry experiences high volume in trading as companies ramp up operations and acquire resources: PetroTech Oil and Gas, Inc. (PTOG), OSL Holdings Inc. (OSLH), The CannaBusiness Group, Inc. (CBGI) and Nuvilex, Inc. (NVLX) PetroTech Oil and Gas, Inc. (PTOG) subsidiary company Legalizepot.us and LP.US Inc., is pleased to announce that Steven Machat (founder & CEO), and Jae Benjamin (president) of Legalize Pot have signed a letter of intent with a large Real Estate group in Seattle Washington, this week to close on a joint venture to open a series of state of the art "green friendly" cannabis retail outlets in the downtown Seattle area. "The initial retail center will house both medicinal and recreational cannabis along with specialty eatables.
Nuvilex Appoints CEO and President of Austrianova to Scientific Advisory Board
Tue, 11 Mar 2014 13:00:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, announced today that its subsidiary, ...
Nuvilex Appoints Dr. Garret L. Yount to Its Subsidiary's Scientific Advisory Board
Fri, 07 Mar 2014 14:00:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, announced today that its subsidiary, ...
NUVILEX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Thu, 06 Mar 2014 22:28:04 GMT
Nuvilex Partner Austrianova Establishes Regional Headquarters and Research and Development Facility at Thailand Science Park for Cell-in-a-Box(TM) Live-Cell Encapsulation
Thu, 06 Mar 2014 16:55:21 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that its strategic partner, ...